27 July 2022
: Case report
Hypoprothrombinemia During Cefmetazole Treatment: A Case Report
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Yuichiro Haba1ABCDEF*, Hikaru Akizuki2ABCDEF, Naoyuki Hashiguchi2ADEF, Toshio Naito
DOI: 10.12659/AJCR.936712
Am J Case Rep 2022; 23:e936712
Figure 2. Clinical course and coagulation tests. APTT – activated partial thromboplastin time; PT-INR – prothrombin time-international normalized ratio; LVFX – levofloxacin; CMZ – cefmetazole; Vit K – vitamin K; PIVKA-II – protein induced by vitamin K absence or antagonist-II; BW – body weight.